Literature DB >> 17200220

Narrative review: reversible cerebral vasoconstriction syndromes.

Leonard H Calabrese1, David W Dodick, Todd J Schwedt, Aneesh B Singhal.   

Abstract

Reversible cerebral vasoconstriction syndromes (RCVS) comprise a group of diverse conditions, all characterized by reversible multifocal narrowing of the cerebral arteries heralded by sudden (thunderclap), severe headaches with or without associated neurologic deficits. Reversible cerebral vasoconstriction syndromes are clinically important because they affect young persons and can be complicated by ischemic or hemorrhagic strokes. The differential diagnosis of RCVS includes conditions associated with thunderclap headache and conditions that cause irreversible or progressive cerebral artery narrowing, such as intracranial atherosclerosis and cerebral vasculitis. Misdiagnosis as primary cerebral vasculitis and aneurysmal subarachnoid hemorrhage is common because of overlapping clinical and angiographic features. However, unlike these more ominous conditions, RCVS is usually self-limited: Resolution of headaches and vasoconstriction occurs over a period of days to weeks. In this review, we describe our current understanding of RCVS; summarize its key clinical, laboratory, and imaging features; and discuss strategies for diagnostic evaluation and treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17200220     DOI: 10.7326/0003-4819-146-1-200701020-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  187 in total

1.  Neurointerventional treatment of amphetamine-induced acute occlusion of the middle cerebral artery by intracranial balloon angioplasty.

Authors:  B Loewenhardt; M Bernhard; A Pierskalla; T Neumann-Haefelin; E Hofmann
Journal:  Clin Neuroradiol       Date:  2011-12-16       Impact factor: 3.649

Review 2.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.

Authors:  C P Marder; M M Donohue; J R Weinstein; K R Fink
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

4.  A case of typical headache with an atypical diagnosis.

Authors:  Alessio Pieroni; Valeria Caso; Elisabetta Cittadini; Mohammed Hamam; Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2012-06-06       Impact factor: 3.397

5.  The posterior reversible encephalopathy syndrome in HIV infection.

Authors:  Sam Nightingale; Chris Wood; Jonathan Ainsworth
Journal:  BMJ Case Rep       Date:  2012-06-25

6.  55-Year-old man with thunderclap headache.

Authors:  Srijana Zarkou; Esma Dilli; David W Dodick
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

7.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

8.  Licorice-associated reversible cerebral vasoconstriction with PRES.

Authors:  N Chatterjee; K Domoto-Reilly; P E Fecci; L H Schwamm; A B Singhal
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

9.  [Reversible cerebral vasoconstriction syndrome vs cerebral vasculitis? On the importance and difficulty of differentiating].

Authors:  M Krämer; P Berlit
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

10.  Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis?

Authors:  L Kraayvanger; P Berlit; P Albrecht; H-P Hartung; M Kraemer
Journal:  Clin Exp Immunol       Date:  2018-07-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.